Home › Funds › GENEVA CAPITAL MANAGEMENT LLC › VCEL
GENEVA CAPITAL MANAGEMENT LLC position in VCEL
VERICEL CORP · Health Care
GENEVA CAPITAL MANAGEMENT LLC reported holding 1,297,344 shares of VCEL (VERICEL CORP) in its Q3 2026 13F filing — a position valued at US$52.1M, representing 1.45% of its reported portfolio and ranking #22 among its reported holdings. GENEVA CAPITAL MANAGEMENT LLC has disclosed VCEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GENEVA CAPITAL MANAGEMENT LLC's VCEL position evolved
GENEVA CAPITAL MANAGEMENT LLC first disclosed a stake in VCEL in Q3 2023 at 435,179 shares (US$14.6M). The position peaked in Q2 2025 at 1,784,927 shares, worth US$75.9M. Across 13 filings, GENEVA CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,297,344 shares valued at US$52.1M — a reduction of -41,779 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2024 (shares fell 12% over the following quarter), a 61% increase in Q3 2024 (shares rose 30% over the following quarter), a 31% increase in Q2 2025 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 435.18K | $14.59M | New |
| Q4 2023 | 472.96K | $16.84M | Add |
| Q1 2024 | 679.16K | $35.33M | Add |
| Q2 2024 | 684.31K | $31.40M | Add |
| Q3 2024 | 1.10M | $46.66M | Add |
| Q4 2024 | 1.10M | $60.39M | Hold |
| Q1 2025 | 1.37M | $60.94M | Add |
| Q2 2025 | 1.78M | $75.95M | Add |
| Q3 2025 | 1.95M | $61.25M | Add |
| Q4 2025 | 1.83M | $65.78M | Reduce |
| Q1 2026 | 1.65M | $52.98M | Reduce |
| Q2 2026 | 1.34M | $59.58M | Reduce |
| Q3 2026 | 1.30M | $52.08M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VCEL and 13F data
VCEL (VERICEL CORP) is a Health Care company. 27 other funds we track also report a position in VCEL — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$102.4M), Soleus Capital Management, L.P. (US$64.9M), Conestoga Capital Advisors, LLC (US$63.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VCEL
- CONGRESS ASSET MANAGEMENT CO 2.55M sh · $102.44M · Q3 2026
- Soleus Capital Management, L.P. 1.46M sh · $64.92M · Q2 2026
- Conestoga Capital Advisors, LLC 1.57M sh · $63.14M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 708.59K sh · $28.44M · Q3 2026
More on GENEVA CAPITAL MANAGEMENT LLC
FAQ
How long has GENEVA CAPITAL MANAGEMENT LLC held VCEL?
GENEVA CAPITAL MANAGEMENT LLC has disclosed VCEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GENEVA CAPITAL MANAGEMENT LLC's current position in VCEL?
As of Q3 2026, GENEVA CAPITAL MANAGEMENT LLC holds 1.30M shares of VCEL (VERICEL CORP), valued at $52.08M, representing 1.45% of its reported portfolio and ranking #22.
Has GENEVA CAPITAL MANAGEMENT LLC been buying or selling VCEL?
In the latest 13F filing (Q3 2026), GENEVA CAPITAL MANAGEMENT LLC reduced its position in VCEL. The position peaked in Q2 2025 at 1.78M shares.
Which other funds hold VCEL?
Other major institutional holders of VCEL include CONGRESS ASSET MANAGEMENT CO, Soleus Capital Management, L.P., Conestoga Capital Advisors, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.